Merck & Co Inc.

2 okt 2026, 23:00 UTC

Merck & Co Inc shares are trading modestly lower in after-market hours, continuing a downward trend amid broader market reactions to disappointing jobs data.

1 okt 2026, 19:46 UTC

Merck & Co Inc shares fell, continuing a downward trend amid concerns over rising inflation and bond yields, while the State Street Health Care Select Sector SPDR also declined.

30 sep 2026, 23:05 UTC

Merck & Co Inc presented results from its Phase 2b trial of MK-7240-012 for hidradenitis suppurativa, with the stock trading slightly lower in after-market hours.

29 sep 2026, 23:05 UTC

Merck & Co Inc is trading lower in after-market hours, slightly down from Tuesday's close after a brief high shortly after 5:40 PM.

28 sep 2026, 19:16 UTC

Merck has secured a global license for SPR2015 from SciBrunch for $400 million, with total potential value reaching $2.13 billion, while shares are trading roughly flat.

25 sep 2026, 23:05 UTC

Merck & Co. has withdrawn its Biologics License Application for ifinatamab deruxtecan after the FDA indicated insufficient trial data, with shares trading lower in after-market hours.

24 sep 2026, 23:30 UTC

Merck & Co Inc's stock traded modestly lower in after-market hours following the announcement of Phase 2b/3 BRUNELLO trial results for diabetic macular edema.

23 sep 2026, 22:51 UTC

Merck & Co Inc is experiencing a modest decline in after-market trading, reflecting a drop from Wednesday's close and positioning near the lower end of its one-month range.

22 sep 2026, 23:06 UTC

Merck & Co Inc's WINREVAIR™ product label update receives FDA approval, contributing to a slight gain in after-market hours following earlier declines.

21 sep 2026, 23:06 UTC

Merck's KEYTRUDA QLEX™ injection has been approved for subcutaneous use in Japan, with the stock remaining roughly flat in after-market trading.

18 sep 2026, 23:06 UTC

Merck & Co Inc declined in after-market trading, moving from a small gain to a modest loss and remaining below its 20-day moving average.

17 sep 2026, 20:07 UTC

Merck's shares are advancing following positive Phase 3 trial results for its collaboration with Moderna on a personalized mRNA cancer therapy for melanoma.

16 sep 2026, 23:51 UTC

Merck & Co Inc is advancing in after-market trading, supported by positive U.S. retail sales data, despite ongoing concerns over TIC flows and Treasury yields.

15 sep 2026, 23:01 UTC

Merck & Co Inc shares are lower in after-market hours. Broader market sentiment is impacted by a significant decline in the New York Empire State Manufacturing Index.

14 sep 2026, 23:06 UTC

Merck & Co Inc shares rose in after-market trading following Monday's close, despite earlier declines and no specific news to explain the movement.

11 sep 2026, 19:36 UTC

Merck & Co Inc shares are declining amid broader market trends following inflation data that heightened interest rate hike speculation. No specific company news was identified.

10 sep 2026, 20:07 UTC

Merck & Co Inc shares are lower today despite HSBC raising its price target to $172 and noting insider buying activity.

9 sep 2026, 19:36 UTC

Merck & Co. shares are lower after a court upheld Medicare's drug-price negotiations, raising concerns about future prescription drug spending.

8 sep 2026, 23:06 UTC

Merck & Co. shares are higher after Karim Mikhail's appointment to lead the FDA's Center for Biologics Evaluation and Research, boosting the company's regulatory reputation.

4 sep 2026, 23:05 UTC

Merck & Co Inc shares are higher in after-market trading, despite no specific news. Broader market signals show mixed economic indicators and rising Treasury yields.

3 sep 2026, 23:05 UTC

Merck & Co Inc shares are lower in after-market hours, reflecting a slight decline since Thursday's close amid broader market gains.

2 sep 2026, 19:46 UTC

Merck & Co Inc is rising following positive results from the ATLAS-UC Phase 3 trial, which met its primary endpoint of clinical significance.

1 sep 2026, 23:07 UTC

Merck & Co Inc. shares were roughly flat during after-market hours, with no specific company news identified amid broader market fluctuations driven by rising oil prices.

31 aug 2026, 23:16 UTC

Merck & Co Inc shares are trading higher in after-market hours. Broader market sentiment is influenced by escalating geopolitical tensions and inflation concerns.

28 aug 2026, 23:01 UTC

Merck & Co Inc shares are higher in after-market trading, supported by rising Treasury yields and trading above their 20-day moving average.

27 aug 2026, 23:01 UTC

Merck & Co Inc. shares are higher in after-market trading, reflecting routine performance despite three consecutive lower sessions. The stock remains above its 20-day moving average.

26 aug 2026, 23:11 UTC

Merck & Co Inc is higher in after-market hours, reflecting broader market gains. The stock remains above its 20-day moving average.

25 aug 2026, 23:06 UTC

Merck & Co Inc reached all-time highs in after-market trading, gaining over $6 amid positive social media sentiment and broader market dynamics.

24 aug 2026, 23:16 UTC

Merck & Co Inc shares are higher in after-market trading, showing stable performance since Monday's close. The stock remains above its 20-day moving average.

21 aug 2026, 19:31 UTC

Merck & Co Inc shares are higher today as Goldman Sachs and Morgan Stanley upgraded their ratings and raised price targets, citing confidence in cancer treatments.